Medical Advisory Board

From its inception, the Lung Cancer Research Foundation has been privileged to have a Medical Advisory Board comprised of renowned, multi-disciplinary scientists and physicians whose expertise spans all lung cancer specialties. Each board member is affiliated with a major cancer center and can apply his or her knowledge to identifying cutting-edge proposals that in future years will make major contributions toward the prevention and treatment of lung cancer.

Julie Brahmer, MD

Associate Professor of Oncology
Sidney Kimmel Comprehensive Cancer
Johns Hopkins University Medical School


Roy Herbst, MD, PhD

Professor of Medicine and Pharmacology
Chief of Medical Oncology
Director, Thoracic Oncology Research Program
Associate Director for Translational Research
Translational Research Program
Yale Comprehensive Cancer Center
Yale School of Medicine


Donald W. Kufe, MD

Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School


Marc Ladanyi, MD

Director, Laboratory of Diagnostic
Molecular Pathology
Memorial Sloan-Kettering Cancer Center


James R. Rigas, MD

Director, Comprehensive Thoracic
Oncology Program
Dartmouth-Hitchcock Medical Center
Norris Cotton Cancer Center
Geisel School of Medicine


Jack A. Roth, MD

Chief, Section of Thoracic Molecular Oncology
MD Anderson Cancer Center
The University of Texas


Charles M. Rudin, MD, PhD

Chief of Thoracic Oncology Service
Memorial Sloan Kettering


Brendon Stiles, MD

Assistant Professor of Cardiothoracic Surgery
Weill Cornell Medical College, New York-Presbyterian Hospital


Ralph R. Weichselbaum MD

Chairman, Department of Radiation and
Cellular Oncology
Director, Ludwig Center for Metastasis Research
University of Chicago Comprehensive
Cancer Center
University of Chicago Medical School


James B. Dougherty, MD

Chair, LCRF Medical Advisory Board
Medical and Scientific Advisor, LCRF Board of Directors
General Partner, Arcus Ventures Fund